Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Malignant”

13,174 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 13,174 results

Early research (Phase 1)Study completedNCT03525925
What this trial is testing

Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid Neoplasm
Ohio State University Comprehensive Cancer Center 16
Not applicableStudy completedNCT02800317
What this trial is testing

RISAS Procedure in Node Positive Breast Cancer Following NAC

Who this might be right for
Breast NeoplasmNeoadjuvant TherapyAxillary Lymph Nodes+1 more
Erasmus Medical Center 248
Not applicableStudy completedNCT03707574
What this trial is testing

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Who this might be right for
Advanced Malignant NeoplasmAdvanced MelanomaAdvanced Renal Cell Carcinoma+51 more
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Study completedNCT02259582
What this trial is testing

Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Nonsquamous Nonsmall Cell Neoplasm of Lung
OncoMed Pharmaceuticals, Inc. 82
Not applicableLooking for participantsNCT05022446
What this trial is testing

The Impact of COVID-19 on Pulmonary Procedures

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 250
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Large-scale testing (Phase 3)UnknownNCT00003603
What this trial is testing

Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Riverside Haematology Group 660
Not applicableUnknownNCT00266370
What this trial is testing

A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant Lymphoma

Who this might be right for
Lymphoma
National Health Research Institutes, Taiwan 100
Testing effectiveness (Phase 2)UnknownNCT00353717
What this trial is testing

Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma

Who this might be right for
Breast Neoplasms
Hadassah Medical Organization 25
Not applicableStudy completedNCT01596790
What this trial is testing

COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
University Hospital, Montpellier 168
Testing effectiveness (Phase 2)UnknownNCT05371223
What this trial is testing

Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases

Who this might be right for
Peritoneal CarcinomatosisPancreas Neoplasm
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 38
Early research (Phase 1)Not Yet RecruitingNCT05474859
What this trial is testing

Subjects With Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Xenthera, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT03895970
What this trial is testing

Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors

Who this might be right for
Liver Neoplasm Malignant PrimaryCholangiocarcinomaCombinational Immunotherapy+1 more
Peking Union Medical College Hospital 32
Testing effectiveness (Phase 2)Ended earlyNCT00020969
What this trial is testing

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
CTI BioPharma
Not applicableStudy completedNCT03357783
What this trial is testing

Macroscopic Deciduosis in Pregnancy is Finally a Common Entity

Who this might be right for
Deciduitis; Complicating Pregnancy
Hôpital NOVO 31
Large-scale testing (Phase 3)Study completedNCT00951574
What this trial is testing

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

Who this might be right for
Advanced CancerMetastatic Cancer
Italfarmaco 1,166
Very early researchLooking for participantsNCT07548697
What this trial is testing

A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma

Who this might be right for
B-cell Non Hodgkin Lymphoma (NHL)DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma (FL)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Not applicableLooking for participantsNCT04243720
What this trial is testing

Immune Resistance Interrogation Study

Who this might be right for
CancerSolid TumorMetastatic Cancer+1 more
University Health Network, Toronto 100
Testing effectiveness (Phase 2)Study completedNCT00390182
What this trial is testing

Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)

Who this might be right for
Gastrointestinal NeoplasmsOvarian Neoplasms
University of Maryland, Baltimore 38
Early research (Phase 1)Study completedNCT00516724
What this trial is testing

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Who this might be right for
Triple Negative Metastatic Breast CancerAdvanced Ovarian CancerCarboplatin+1 more
AstraZeneca 189
Next Page